SCHOFIELD, Wis., July 22, 2014 /PRNewswire/ -- PuraMed
BioScience®, Inc., (OTCBB: PMBS), a researcher, developer, and
marketer of over-the-counter (OTC) medicinal and healthcare
products, announced today that the company is a corporate sponsor
of Operation Troop Aid.
"We are pleased to sponsor Operation Troop Aid," said
Russell Mitchell, CEO and Chairman
of PuraMed BioScience. "Research shows that many service men and
women in combat zones experience migraines much more frequently than the
general population. Providing those people with LipiGesic® M, our
highly effective migraine medication, can help them relieve
migraines while they are serving
our country."
Currently, Operation Troop Aid ships between 15 and 20 thousand
individual care packages overseas to deployed service men and women
each year. Operation Troop Aid's future expansion plans include a
veteran's care network that will incorporate music therapy and
recovery retreats in addition to the development of a special
care-package program for children whose mothers or fathers are
deployed.
"We appreciate PuraMed's generous donation of LipiGesic M to our
program," said Mark H. Woods, LT
(03-E) USN Ret, CEO of Troop Aid. "Our Troops have been on
exhaustive arduous deployments during the last 13 years. Some have
been deployed as many as 10 times. Operation Troop Aid care
packages provide our troops with encouragement from home and proof
that people in their homeland care about them and appreciate what
they are doing."
"Operation Troop Aid's mission to provide assistance and
encouragement to military personnel and veterans aligns with our
passion to help people who suffer from debilitating migraines,"
said Mitchell. "We know that many service men and women who have
experienced combat have a higher incidence of migraine, which is often accompanied by Post
Traumatic Stress Disorder (PTSD). Introducing military personnel to
LipiGesic M during deployment can also help them as they return to
civilian life, especially if they experience PTSD, since LipiGesic
M does not interfere with commonly prescribed PTSD medications. We
look forward to working with Operation Troop Aid."
About LipiGesic® M
LipiGesic M is a clinically tested, all-natural,
over-the-counter migraine headache pain relief medication that
quickly stops disabling migraine pain and associated symptoms.
LipiGesic M's feverfew and ginger gel is non-drowsy and non-habit
forming. Unlike the commonly prescribed prescription and OTC
migraine treatments, LipiGesic M is not associated with rebound
headaches. LipiGesic M has an excellent safety profile and has no
reported drug interactions.
About Operation Troop Aid
In 2003, Operation Troop Aid incorporated as a charity and was
granted non-profit 501c3 status by the Internal Revenue Service.
Operation Troop Aid is a Premier Care Package and Bill Assistance
Charity for all branches of the U.S. military. The mission of
Operation Troop Aid is to make a positive difference and inspire
U.S. service members by:
- distributing Care Packages to U.S. Troops who are deployed
- providing human and social services to help military personnel
and veterans who have needs not met by other agencies
- facilitating community awareness programs to initiate
communication between communities and the Troops
Operation Troop Aid raises funds through major concert
promotions, entertainment initiatives, and the generosity of
corporate and individual sponsors, and local community fund drives
and events. For more information about Operation Troop Aid visit
www.operationtroopaid.org.
About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and
marketing of non-prescription medicinal and healthcare products. In
addition to LipiGesic M, PuraMed BioScience plans to launch
additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic
products as it moves forward in the development of its CBD product
line.
Forward-Looking Statements
This news release contains forward-looking statements regarding
PuraMed BioScience, Inc., and its future business plans, which
statements involve known and unknown risks and uncertainties. Such
risks and uncertainties may cause actual results and future
achievements of PuraMed BioScience to be materially different from
those implied by these forward-looking statements. PuraMed
BioScience has and undertakes no obligation to provide public
updates and revisions to these forward-looking statements to
reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and
CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com
SOURCE PuraMed BioScience, Inc.